SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksElementis Regulatory News (ELM)

Share Price Information for Elementis (ELM)

Share Price is delayed by 15 minutes
Get Live Data
154.40    1.60 (1.05%)
Bid:
154.40
Ask:
154.80
Spread: 0.40 (0.259%)
Market Cap: £883.65m
ELM Live PriceLast checked at - London Stock Exchange

Intraday Elementis Share Chart

Interim Management Statement

25 Oct 2013 07:00

RNS Number : 3576R
Elementis PLC
25 October 2013
 



 

 

Elementis - Interim Management Statement

 

Elementis plc (ELM.L, "Elementis" or "the Group"), the Global Specialty Chemicals Company, today issues its Interim Management Statement for the three months ended 30 September 2013.

 

Commenting on the Group's performance Group Chief Executive, David Dutro, said:

"Elementis is pleased to report another resilient performance in spite of an economic background where growth is turning out to be slower than generally anticipated. The Group's strategy of creating its own growth opportunities, combined with its strong, diverse market positions and a return to more normal trading patterns in oilfield drilling are the key drivers of the Group's 12 per cent sales growth in the current quarter, compared to the same period last year. The integration of the Group's two recent acquisitions, Watercryl in Brazil and Hi-Mar in the US, is progressing well and the second and final phase of our new coatings additives plant in North America is well underway. These investments strengthen the broad geographic presence and enhance the Group's exciting market positions and will support further growth over the medium term."

 

 

Specialty Products sales improved by 15 per cent, or 8 per cent excluding acquisitions and currency.

 

· In coatings, sales in North America were higher by 12 per cent, mainly due to the acquisition of Hi-Mar earlier in the year. In Asia Pacific, sales increased by 11 per cent as the business continued to benefit from its market position in China, experiencing strong demand from local high-end industrial markets. Latin American sales increased by 68 per cent, driven by the acquisition of Watercryl in September 2012, and good progress is being made in expanding Watercryl sales outside of Brazil. In Europe, underlying economic conditions continue to be subdued as headline sales improved by 3 per cent, with currency contributing 4 per cent.

 

· In personal care, the business continued to benefit from the initiatives of a refocused management structure, with additional resources in new geographies and new product launches. As a result, sales improved by 16 per cent or 13 per cent excluding currency.

 

· Sales to the oil and gas drilling sector continued to demonstrate a sustained recovery following the impact of industry destocking in the latter part of 2012, maintaining the robust pace reported for the first six months of the year. Consequently, sales to this sector were at a similar level to the average quarterly sales in the first half of this year and 35 per cent ahead of the same period last year.

 

· Operating margin in the third quarter was similar to that reported for the first six months of the year as overall pricing and contribution margins remained stable.

 

As expected, following the planned maintenance shutdown in the early part of the year, Chromium trading patterns in the current quarter returned to more normal levels. Chromium sales in the quarter were 5 per cent ahead of the same period last year and at a similar level to the second quarter of the current year. As production volumes and plant utilisation returned to more normal levels, margins improved compared to the first half of the year and operating margin for the full year is expected to be in the range of 24-26 per cent. Consistent with our strategy of stable earnings and cash flow, we expect the performance of Chromium in the second half of 2013 will be similar to the second half of last year.

 

Cash flow continues to be a positive aspect of the Group's performance and it is anticipated that the end of year balance sheet will show a net cash balance of at least $30 million.

 

Overall we remain confident in the Group's ability to deliver growth that is in excess of the underlying economies in which it operates and expect our full year earnings per share to be in line with market expectations.

 

 

 

 

 

Enquiries:

Elementis + 44 (0) 207 408 9300

Brian Taylorson, Finance Director

  

FTI Consulting

 + 44 (0) 207 831 3113

Deborah Scott

Matthew Cole

  

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSUSOVROUARUAA
Date   Source Headline
2nd Dec 201912:15 pmPRNTotal Voting Rights
19th Nov 20197:00 amRNS2019 Capital Markets Day
1st Nov 20199:33 amPRNTotal Voting Rights
31st Oct 20197:00 amRNSQ3 Trading Update
4th Oct 20197:52 amPRNDirectorate Change
30th Sep 20197:00 amPRNAppointment of joint corporate broker
2nd Sep 201910:00 amPRNBlocklisting - Interim Review
15th Aug 201910:34 amPRNDirector/PDMR Shareholding
1st Aug 20193:42 pmPRNHolding(s) in Company
30th Jul 20197:00 amRNSHalf-year Report
25th Jul 201910:14 amPRNHolding(s) in Company
6th Jun 20195:42 pmPRNDirector/PDMR Shareholding
6th Jun 20195:39 pmPRNDirector/PDMR Shareholding
7th May 201910:33 amPRNDirector Declaration
7th May 20198:57 amPRNDirector Declaration
2nd May 20192:38 pmPRNHolding(s) in Company
30th Apr 20191:00 pmPRNResult of AGM
30th Apr 20197:00 amRNSAGM Trading Statement
18th Apr 20193:23 pmPRNHolding(s) in Company
17th Apr 20192:43 pmPRNHolding(s) in Company
3rd Apr 20199:31 amPRNDirector/PDMR Shareholding
3rd Apr 20199:27 amPRNDirector/PDMR Shareholding
29th Mar 201910:53 amPRNHolding(s) in Company
22nd Mar 20191:08 pmPRNAnnual Financial Report
15th Mar 20194:20 pmPRNDirector/PDMR Shareholding
12th Mar 20197:38 amPRNDirector/PDMR Shareholding
12th Mar 20197:35 amPRNDirector/PDMR Shareholding
12th Mar 20197:35 amPRNDirector/PDMR Shareholding
5th Mar 20197:00 amRNS2018 Preliminary Results Announcement
1st Mar 20191:40 pmPRNBlocklisting - Interim Review
5th Feb 20199:20 amPRNHolding(s) in Company
31st Jan 201911:39 amPRNTotal Voting Rights
23rd Jan 20194:00 pmPRNHolding(s) in Company
21st Jan 201911:36 amPRNHolding(s) in Company
15th Jan 20194:15 pmPRNHolding(s) in Company
15th Jan 20194:00 pmPRNHolding(s) in Company
10th Jan 201911:30 amPRNHolding(s) in Company
7th Jan 20192:15 pmPRNHolding(s) in Company
31st Dec 20189:00 amPRNTotal Voting Rights
27th Dec 201811:00 amPRNHolding(s) in Company
20th Dec 20183:11 pmPRNAcquisition of advantaged manufacturing site in India
18th Dec 20189:36 amPRNDirector/PDMR Shareholding
14th Dec 20184:20 pmPRNHolding(s) in Company
11th Dec 201810:33 amPRNDirector/PDMR Shareholding
3rd Dec 20182:25 pmPRNTotal Voting Rights
29th Nov 20188:10 amPRNDirector/PDMR Shareholding
29th Nov 20187:00 amPRNDirector/PDMR Shareholding
22nd Nov 20182:02 pmPRNDirector/PDMR Shareholding
5th Nov 20187:00 amPRNAppointment of new broker
1st Nov 201810:05 amPRNTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.